Myriad Genetics, Inc. (NASDAQ:MYGN) Q2 2021 Earnings Conference Call August 3, 2021 4:30 PM ET Company Participants Nathan Smith – Senior Vice President-Investor Relations and Treasury Paul Diaz – President and Chief Executive Officer Bryan Riggsbee – Chief Financial Officer Conference Call Participants Sung Ji Nam – BTIG Andrew Cooper – Raymond James Matt Sykes – Goldman Sachs Jack Meehan – Nephron Research Operator Greetings, and welcome to the Myriad Genetics Second Quarter 2021 Earnings Call. During the ...

Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2021 Earnings Conference Call November 9, 2020 5:00 PM ET Company Participants Scott Gleason – Senior Vice President of Investor Relations and Corporate Strategy Paul Diaz – President and Chief Executive Officer Bryan Riggsbee – Chief Financial Officer Conference Call Participants Doug Schenkel – Cowen Steve Unger – Needham Tycho Peterson – JPMorgan Puneet Souda – SVB Leerink Derik de Bruin – Bank of America Jack Meehan – Nephron Operator Greetings and welcome to the M ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________ FORM 10-Q _________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0-26642 _________________ ...